This article is part of a series sponsored by HLTH, HLTH Conference November 13-16 in Las Vegas. Evernow’s Alicia Jackson will join her discussion on the Gallery Stage Women’s Health Care panel on Monday, November 14, from 11:50 p.m. to 12:20 p.m.
Alicia Jackson is the CEO and founder of Evernow, a healthcare company designed to help women over the age of 40 meet their changing healthcare needs. In response to a question posed in her email, she talked about why she started her company and how the company is responding to the changing legal landscape for women’s health following legislative changes. did. Law vs. Wade by the US Supreme Court.
What drew you to healthcare? What were you doing before joining this company?
I’ve been a scientist most of my life because I’m drawn to solving big problems. I have a Ph.D. from his MIT and have spent much of my career studying science in Washington. He eventually served as Deputy Director of DARPA’s Office of Biotechnology, managing a $300 million portfolio.
During his time at DARPA, he became interested in what was achieved by bringing the best of biotechnology into the startup space, eventually moving to San Francisco and co-founding Drawbridge Health with GE. This experience started to pave the way for my current job. Having thought a lot about how hormonal changes affect fertility, I soon realized what happens during menopause and how important menopause is for women.
Hormonal changes can have a profound impact on both short-term and long-term health and represent a true crossroads in women’s healthcare journeys.In light of this, more research is needed. And it was clear that more action was needed on that research. Half the population is a very attractive place to double if you’re looking for big problems.
Alicia Jackson
what does your company do? What kind of services do you offer?
Evernow is a healthcare company for late-life women. This usually means a woman over the age of 40 who is experiencing hormonal changes associated with perimenopause and menopause. We have been offering Hormone Therapy (HT) plans from day one. As a team of scientists and engineers, we take great pride in our ability to actually track and advance the latest research.
Whether a woman chooses HT or not, we provide 24/7 virtual care from a dedicated medical team for all aspects of hormonal health. Our member does not have to wait more than her 24 hours to get an answer. We think this is important because the symptoms that women go through at this time in their lives can be quite surprising and even frightening. We have also launched a program and an app to help members manage their health.
In addition to our daily collaboration with our members, we are also committed to advancing science through research. Ongoing menopausal research involving more than 100,000 women will highlight how menopausal symptoms are affected by race at a meeting of the North American Menopause Society this fall. We published a poster on a subset of this data. This poster represents the largest body of research of its kind and we believe it can play a role in creating better and more comprehensive care delivery. Not only that, but we are really focused on the potential of telemedicine to actually improve care.
What are the unmet or undermet needs your company is trying to provide?
Imagine if there was one important factor that greatly impacted your lifespan, but you had no way to learn about it and few options to deal with it. That’s the reality for generations of women facing menopause. It’s a critical time for so many health aspects, from metabolic health to brain health to cardiovascular health. But until recently, there weren’t many products for women because the problem was complex and there were centuries of precedents that overshadowed it. We are here to scientifically innovate what can be done.
What niche are you filling?
For too long, menopause has been under-researched, under-invested, and under-served during what can be an incredibly difficult time. Built with the ability to meet the evolving needs of its members, Evernow provides a core backbone of expert clinical support, informed by detailed patient data. and provide the right personalized care at the right time. We consider ourselves part of our members’ long-term health and science teams, using our research to continuously improve women’s health care for the second half of life. .
Who are your target customers?
Our clinic mainly targets women over 40 who are suffering from menopause and menopause. To give a sense of scale, more than 2 million women enter the menopausal transition each year, and it’s a journey that could last her 10 to 20 years. Nevertheless, 75% of those seeking treatment do not receive it. We are here to meet their needs, both in the care we provide today and in how we advance science for tomorrow.
Are there any challenges that Roe v Wade’s overturn and state-imposed abortion restrictions pose to the health of the women your business is addressing?
Women over the age of 40 can and do become pregnant. Also, not enough is said about the possibility of getting pregnant while on hormone therapy. Mid-life pregnancies are more likely to end in miscarriage and are more likely to have ectopic pregnancies. There is now a lot of confusion about when and how doctors can treat these patients. We really see ourselves as a source of information for women during this time of hormonal change. And now, this feels more important than ever.
What’s on your to-do list for 2022-2023? What milestones are you trying to reach in the next 18 months?
Our vision for the next 18 months is to serve more women’s needs. We continue to expand the functionality of our app and our new flexible care platform. This establishes them as long-term care partners who can meet their needs wherever they are on their journey. While doing this, we are also looking to expand our therapies (Rx, OTC, and digital programs) to address a wider range of menopause-related symptoms. We dig even deeper into our research to provide better insights and help us create better and more comprehensive solutions for women everywhere.
Photo: marchmeena29, Getty Images
